Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections

Combination of caspofungin and another anti-fungal agent raise expectation of improved efficacy in severe fungal infections including failures to first line therapy. We assessed the efficacy and safety of a combination therapy including caspofungin in 17 immunosuppressed or postoperative patients pr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infection 2006, Vol.52 (1), p.67-74
Hauptverfasser:	Nivoix, Y., Zamfir, A., Lutun, P., Kara, F., Remy, V., Lioure, B., Rigolot, J.C., Entz-Werlé, N., Letscher-Bru, V., Waller, J., Levêque, D., Koffel, J.C., Beretz, L., Herbrecht, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Amphotericin B Amphotericin B - administration & dosage Amphotericin B - adverse effects Amphotericin B - therapeutic use Antibiotics. Antiinfectious agents. Antiparasitic agents Antifungal agents Antifungal Agents - administration & dosage Antifungal Agents - therapeutic use Antiparasitic agents Azole Biological and medical sciences Candidemia Caspofungin Child, Preschool Combination therapy Drug Therapy, Combination Echinocandins Fluconazole - administration & dosage Fluconazole - therapeutic use Fungal infections General aspects Humans Invasive aspergillosis Lipopeptides Medical sciences Middle Aged Mycoses - drug therapy Peptides, Cyclic - administration & dosage Peptides, Cyclic - adverse effects Peptides, Cyclic - therapeutic use Pharmacology. Drug treatments Risk Factors Scedosporium
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!